Technology
Health
Biotechnology

Aldeyra Therapeutics

$4.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.82%) Today
$0.00 (0.00%) As of 4:25 PM EDT after-hours

Why Robinhood?

You can buy or sell ALDX and other stocks, options, ETFs, and crypto commission-free!

About ALDX

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. Read More The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Employees
19
Headquarters
Lexington, Massachusetts
Founded
2004
Market Cap
134.03M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
174.61K
High Today
$5.03
Low Today
$4.78
Open Price
$4.95
Volume
236.15K
52 Week High
$16.70
52 Week Low
$4.75

Collections

Technology
Health
Biotechnology
Therapy
2014 IPO
US
North America

ALDX News

ReutersAug 11

Edited Transcript of ALDX earnings conference call or presentation 8-Aug-19 12:00pm GMT

2

ALDX Earnings

-$0.52
-$0.46
-$0.39
-$0.33
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.49 per share
Actual
-$0.49 per share

More ALDX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.